한독 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 와이앤에스인터내셔날, was filed 04 Jun 2026.
한독: what insiders have been doing
This page follows insider dealings at 한독 as filed with DART (FSS), a company from the Health Care sector. In the past year (2 November 2025 to 2 November 2026), 8 filings came from 4 insiders.
Open-market activity splits into 3 purchases totalling €282k and 1 sale; 2 insiders sit on the buying side and 1 insider on the selling side. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €282k from 와이앤에스인터내셔날, disclosed on 4 June 2026. On the buying side, the filings list 1 senior executive among the declarants.
The latest purchase dates back some time: it was published 157 days ago, on 4 June 2026. Typically, a trade is published a median of 7 days after it takes place. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (2,655 companies, median 7 filings), a count of 8 filings is above the norm. Over the whole record (from 2021), the tally stands at 7 purchases and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +1.0%Entry ₩8,130 · Close 30 Oct 2026 ₩8,210
- -23.3%Entry ₩10,700 · Close 30 Oct 2026 ₩8,210
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 170,028 sharesKRXDART:20260604000318
- 56,676 shares@ ₩8,800.00100.0% of flowShareKRXDART:20260604000304Canonical exit: 30 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260519000023Canonical exit: 17 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260313000270Canonical exit: 1 Jun 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20241227000051
- 2,338,269 sharesKRXDART:20241216000213Canonical exit: 13 Mar 2025 (T+90)
- 0KRXDART:20240701000200
- 0KRXDART:20231005000089
- 0KRXDART:20230703000201
- ShareKRXDART:20230331002394Canonical exit: 29 Jun 2023 (T+90)
- ●Executives0DART
- 0KRXDART:20221228000144
- 0KRXDART:20221006000443
- 0KRXDART:20220816000084
- 0KRXDART:20220707000083
25 of 33 declarations
About 한독
HanDoc is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations